{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:04:19Z","timestamp":1794895459027,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K08427"],"award-info":[{"award-number":["JP23K08427"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43172-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:03:08Z","timestamp":1772805788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03b2-Nicotinamide mononucleotide preserves muscle strength in septic male mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Mari","family":"Saida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Sawatsubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Kanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"43172_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"43172_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/CCM.0b013e318232da75","volume":"40","author":"DM Needham","year":"2012","unstructured":"Needham, D. M. et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders\u2019 conference. Crit Care Med 40, 502\u2013509 (2012).","journal-title":"Crit Care Med"},{"key":"43172_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0993-7","volume":"19","author":"G Hermans","year":"2015","unstructured":"Hermans, G. & Van den Berghe, G. Clinical review: Intensive care unit acquired weakness. Crit. Care 19, 274 (2015).","journal-title":"Crit. Care"},{"key":"43172_CR4","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00134-007-0772-2","volume":"33","author":"RD Stevens","year":"2007","unstructured":"Stevens, R. D. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33, 1876\u20131891 (2007).","journal-title":"Intensive Care Med"},{"key":"43172_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.792201","volume":"9","author":"X Chen","year":"2022","unstructured":"Chen, X., Lei, X., Xu, X., Zhou, Y. & Huang, M. Intensive care unit-acquired weakness in patients with extracorporeal membrane oxygenation support: Frequency and clinical characteristics. Front. Med. 9, 792201 (2022).","journal-title":"Front. Med."},{"key":"43172_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00134-020-06244-7","volume":"46","author":"N Van Aerde","year":"2020","unstructured":"Van Aerde, N. et al. Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med 46, 2083\u20132085 (2020).","journal-title":"Intensive Care Med"},{"key":"43172_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787\u20131794 (2010).","journal-title":"JAMA"},{"key":"43172_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49920","author":"AM Owen","year":"2019","unstructured":"Owen, A. M. et al. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model. Elife https:\/\/doi.org\/10.7554\/eLife.49920 (2019).","journal-title":"Elife"},{"key":"43172_CR9","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcsm.13548","volume":"15","author":"Y Akama","year":"2024","unstructured":"Akama, Y. et al. Roles of programmed death-1 and muscle innate lymphoid cell-derived interleukin 13 in sepsis-induced intensive care unit-acquired weakness. J. Cachexia Sarcopenia Muscle 15, 1999\u20132012 (2024).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"43172_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00982-w","volume":"30","author":"MS Kingren","year":"2024","unstructured":"Kingren, M. S. et al. Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria. Mol. Med. 30, 221 (2024).","journal-title":"Mol. Med."},{"key":"43172_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2657-5","volume":"23","author":"ARH van Zanten","year":"2019","unstructured":"van Zanten, A. R. H., De Waele, E. & Wischmeyer, P. E. Nutrition therapy and critical illness: Practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit. Care 23, 368 (2019).","journal-title":"Crit. Care"},{"key":"43172_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.clnu.2023.07.011","volume":"42","author":"P Singer","year":"2023","unstructured":"Singer, P. et al. ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit. Clin. Nutr. 42, 1671\u20131689 (2023).","journal-title":"Clin. Nutr."},{"key":"43172_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S2213-2600(13)70183-8","volume":"1","author":"G Hermans","year":"2013","unstructured":"Hermans, G. et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: A subanalysis of the EPaNIC trial. Lancet Respir. Med. 1, 621\u2013629 (2013).","journal-title":"Lancet Respir. Med."},{"key":"43172_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223185","volume":"14","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Early mobilization of critically ill patients in the intensive care unit: A systematic review and meta-analysis. PLoS ONE 14, e0223185 (2019).","journal-title":"PLoS ONE"},{"key":"43172_CR15","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1073\/pnas.0803790105","volume":"105","author":"BH Ahn","year":"2008","unstructured":"Ahn, B. H. et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105, 14447\u201314452 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"43172_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/SHK.0000000000000799","volume":"47","author":"AM Steele","year":"2017","unstructured":"Steele, A. M., Starr, M. E. & Saito, H. Late therapeutic intervention with antibiotics and fluid resuscitation allows for a prolonged disease course with high survival in a severe murine model of sepsis. Shock 47, 726\u2013734 (2017).","journal-title":"Shock"},{"key":"43172_CR17","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1038\/ncomms10145","volume":"6","author":"P Rocheteau","year":"2015","unstructured":"Rocheteau, P. et al. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat Commun 6, 10145 (2015).","journal-title":"Nat Commun"},{"key":"43172_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05462-z","volume":"29","author":"A Pierre","year":"2025","unstructured":"Pierre, A. et al. Muscle weakness after critical illness: Unravelling biological mechanisms and clinical hurdles. Crit. Care 29, 248 (2025).","journal-title":"Crit. Care"},{"key":"43172_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35001622","volume":"403","author":"S Imai","year":"2000","unstructured":"Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795\u2013800 (2000).","journal-title":"Nature"},{"key":"43172_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464\u2013471 (2014).","journal-title":"Trends Cell Biol."},{"key":"43172_CR21","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1128\/MCB.01636-07","volume":"27","author":"DB Lombard","year":"2007","unstructured":"Lombard, D. B. et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell Biol. 27, 8807\u20138814 (2007).","journal-title":"Mol. Cell Biol."},{"key":"43172_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","volume":"35","author":"E Verdin","year":"2010","unstructured":"Verdin, E., Hirschey, M. D., Finley, L. W. & Haigis, M. C. Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends Biochem. Sci. 35, 669\u2013675 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"43172_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/CCM.0000000000001658","volume":"44","author":"S Yende","year":"2016","unstructured":"Yende, S. et al. Long-term quality of life among survivors of severe sepsis: Analyses of two international trials. Crit. Care Med. 44, 1461\u20131467 (2016).","journal-title":"Crit. Care Med."},{"key":"43172_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05080-1","volume":"28","author":"S Ge","year":"2024","unstructured":"Ge, S. et al. Post-discharge functional outcomes in older patients with sepsis. Crit. Care. 28, 281 (2024).","journal-title":"Crit. Care."},{"key":"43172_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01233-7","volume":"14","author":"M Ibarz","year":"2024","unstructured":"Ibarz, M., Haas, L. E. M., Ceccato, A. & Artigas, A. The critically ill older patient with sepsis: A narrative review. Ann. Intensive Care. 14, 6 (2024).","journal-title":"Ann. Intensive Care."},{"key":"43172_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116004","volume":"170","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q., Siyuan, Z., Xing, C. & Ruxiu, L. SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy. Biomed. Pharmacother. 170, 116004 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"43172_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01006","volume":"10","author":"Y Han","year":"2019","unstructured":"Han, Y., Zhou, S., Coetzee, S. & Chen, A. SIRT4 and its roles in energy and redox metabolism in health, disease and during exercise. Front. Physiol. 10, 1006 (2019).","journal-title":"Front. Physiol."},{"key":"43172_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02341","volume":"10","author":"T Heinonen","year":"2019","unstructured":"Heinonen, T., Ciarlo, E., Le Roy, D. & Roger, T. Impact of the dual deletion of the mitochondrial sirtuins SIRT3 and SIRT5 on anti-microbial host defenses. Front. Immunol. 10, 2341 (2019).","journal-title":"Front. Immunol."},{"key":"43172_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","volume":"143","author":"S Someya","year":"2010","unstructured":"Someya, S. et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802\u2013812 (2010).","journal-title":"Cell"},{"key":"43172_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1021\/bi901627u","volume":"49","author":"H Cimen","year":"2010","unstructured":"Cimen, H. et al. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49, 304\u2013311 (2010).","journal-title":"Biochemistry"},{"key":"43172_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu, X., Brown, K., Hirschey, M. D., Verdin, E. & Chen, D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662\u2013667 (2010).","journal-title":"Cell Metab."},{"key":"43172_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","volume":"38","author":"P Singer","year":"2019","unstructured":"Singer, P. et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin. Nutr. 38, 48\u201379 (2019).","journal-title":"Clin. Nutr."},{"key":"43172_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00134-024-07458-9","volume":"50","author":"AME de Man","year":"2024","unstructured":"de Man, A. M. E., Gunst, J. & Reintam Blaser, A. Nutrition in the intensive care unit: From the acute phase to beyond. Intensive Care Med. 50, 1035\u20131048 (2024).","journal-title":"Intensive Care Med."},{"key":"43172_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021282","volume":"99","author":"W Zhou","year":"2020","unstructured":"Zhou, W., Shi, B., Fan, Y. & Zhu, J. Effect of early activity combined with early nutrition on acquired weakness in ICU patients. Medicine 99, e21282 (2020).","journal-title":"Medicine"},{"key":"43172_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11914-022-00746-7","volume":"20","author":"LS Chapple","year":"2022","unstructured":"Chapple, L. S., Parry, S. M. & Schaller, S. J. Attenuating muscle mass loss in critical illness: The role of nutrition and exercise. Curr. Osteoporos. Rep. 20, 290\u2013308 (2022).","journal-title":"Curr. Osteoporos. Rep."},{"key":"43172_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04767-3","volume":"21","author":"T Cao","year":"2023","unstructured":"Cao, T. et al. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis. J. Transl. Med. 21, 883 (2023).","journal-title":"J. Transl. Med."},{"key":"43172_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098972","volume":"9","author":"T Yamamoto","year":"2014","unstructured":"Yamamoto, T. et al. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE 9, e98972 (2014).","journal-title":"PLoS ONE"},{"key":"43172_CR38","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41401-024-01424-3","volume":"46","author":"R Ni","year":"2025","unstructured":"Ni, R. et al. Nicotinamide mononucleotide protects septic hearts in mice via preventing cyclophilin F modification and lysosomal dysfunction. Acta Pharmacol. Sin. 46, 976\u2013988 (2025).","journal-title":"Acta Pharmacol. Sin."},{"key":"43172_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407768121","volume":"121","author":"H Sakai","year":"2024","unstructured":"Sakai, H. et al. The androgen receptor in mesenchymal progenitors regulates skeletal muscle mass via Igf1 expression in male mice. Proc. Natl. Acad. Sci. U. S. A. 121, e2407768121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"43172_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S. I. NAD(+) intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528 (2018).","journal-title":"Cell Metab."},{"key":"43172_CR41","first-page":"52076","volume":"97","author":"T Lampl","year":"2015","unstructured":"Lampl, T., Crum, J. A., Davis, T. A., Milligan, C. & Del Gaizo Moore, V. Isolation and functional analysis of mitochondria from cultured cells and mouse tissue. J Vis Exp 97, 52076 (2015).","journal-title":"J Vis Exp"},{"key":"43172_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00678-8","volume":"18","author":"N Saeki","year":"2020","unstructured":"Saeki, N. & Imai, Y. Reprogramming of synovial macrophage metabolism by synovial fibroblasts under inflammatory conditions. Cell Commun. Signal. 18, 188 (2020).","journal-title":"Cell Commun. Signal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43172-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43172-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43172-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:03:29Z","timestamp":1773403409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43172-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43172-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8905"}}